“Don't take it just from me: https://foreignpolicy.com/2019/08/14/u-s-sanctions-are-killing-cancer-patients-in-iran/ illustrates one impact of the Trump administration's #EconomicTerrorism on Iranians; from those directly involved in producing medicine for cancer patients,” Zarif said on his twitter account on Friday.
Titled “US Sanctions Are Killing Cancer Patients in Iran”, the Foreign Policy’s report said, “Washington claims that maximum pressure (on Iran) won’t stop the supply of medicine and other humanitarian necessities, but banking sanctions are driving up import prices, blocking supply chains, and creating deadly drug shortages.”
“Just as with raw materials, banking restrictions have made it more difficult for Iranian importers to pay European and Asian suppliers for medicine. Shortages of imported medicines and skyrocketing costs are putting the most vulnerable patients —those with rare or advanced diseases—at the greatest risk,” the report stated.